| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MYRIAD GENETICS INC | Director | Common Stock | 82.3K | $1.82M | $22.05 | Jun 6, 2024 | Direct |
| Coherus BioSciences, Inc. | Director | Stock Option (Right to Buy) | 112K | Jun 3, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| CHRS | Coherus BioSciences, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director |
| MYGN | MYRIAD GENETICS INC | May 13, 2024 | 1 | -$157K | 4 | May 15, 2024 | Director |
| CHRS | Coherus BioSciences, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 1, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| CHRS | Coherus BioSciences, Inc. | Feb 2, 2022 | 1 | $0 | 4 | Feb 4, 2022 | Director |
| CHRS | Coherus BioSciences, Inc. | Feb 2, 2022 | 0 | $0 | 3 | Feb 4, 2022 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 3, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |